Function
Mediate stress response via cortisol and catecholamines
Site of secondary sex hormone synthesis and BP regulation.
Structure
Cortex - derived from mesothelium
Medulla - derived from neural crest cells
Avg thickness ~3 mm for medial/lateral limbs; >10 mm can be used as hyperplasia threshold
Adrenal cortex:
Consists 3 layers that synthesize distinct hormones derived from cholesterol (superficial -> deep):
Zona glomerulosa (mineralocorticoids) - produces aldosterone
Zona fasciculata (glucocorticoids) - responds to ACTH to produce GC
Zona reticularis (androgens) - produces androgens
Adrenal hyperplasia, adenoma, and cortical carcinoma are lesions that can be diagnosed on imaging.
Adrenal medulla:
Secrete catecholamines into bloodstream; norepinephrine and epinephrine derived from tyrosine.
Masses that arise in medulla include...
Pheochromocytomas
Neuroblastic tumors (ganglioneuroma, ganglioneuroblastoma, neuroblastoma)
Arteries:
Superior adrenal: 6-8; from inferior phrenic arteries
Middle adrenal: 1; from abdominal aorta
Inferior adrenal: 1; from renal arteries
Veins:
Right AG drains into IVC
L adrenal drains into L renal vein
Presynaptic SNS fibers from paravertebral ganglia end directly on secretory cells of medulla.
Cushing syndrome:
Excess cortisol via...
Exogenous admin
Endogenous production 2/2...
Pituitary dz: Cushing dz
Nonpituitary dz:
Idiopathic adrenal hyperplasia
Adrenal adenoma
Ectopic/paraneoplastic ACTH (SCLC)
Conn syndrome:
Excess aldosterone production (usually 2/2 adrenal adenoma) -> HTN and hypokalemia.
Adenomas implicated in CS are typically small and may be difficult to detect on CT.
Localizing side of excess hormone production w/ venous sampling may be a helpful diagnostic adjunct.
Adrenal cortical carcinoma:
Very rare malignancy that arises from the cortex
Typically causes an increase in levels of all cortical adrenal hormones and their precursors.
Pheochromocytoma
Usually arise from adrenal medulla
Can be assoc w/ excess catecholamine production.
Sx: episodic HA, tachycardia, diaphoresis, and uncontrolled HTN
Substantial destruction of adrenal tissue is required to produce adrenal insufficiency.
Addison dz
NOT an imaging diagnosis
Chronic adrenocortical insufficiency
Can be 2/2 autoimmune destruction and AGs or by prior infection.
Waterhouse-Friderichsen syndrome
Post-hemorrhagic adrenal failure 2/2 Neisseria Meningitidis bacteremia
Idiopathic adrenal hemorrhage:
Usually unilateral and rarely causes adrenal hypofunction
ADRENAL WASHOUT CT
Most useful for distinguishing AA from emts in patients w/ known nonhypervascular primary malignancy.
Washout CT findings should not be stand-alone features for diagnosis of lipid-poor adenoma; other features such as mass size, heterogeneity, and clinical context should be considered.
Adrenal protocol: 3 phases
NECT
If <10 HU on NECT = AA -> no further WU
If >10 HU on NECT -> 60 sec + delayed CECT
CECT - adrenal parenchymal phase @ 60 sec
Delayed CECT 15 min
If NECT images are unavailable, relative washout calculation can still be performed.
AAs demonstrate rapid washout
Adrenal mets demonstrate slow washout: <60% absolute; <40% relative)
In a pt w/ a known primary malignancy, lesions that do not demonstrate benign washout kinetics are suspicious for, but not diagnostic of, mets.
Some malignant adrenal mass may rarely contain intracytoplasmic lipid and lose signal on OOP:
Well differentiated adrenocortical carcinoma
Metastatic clear cell RCC
metastatic HCC
Liposarcoma
Benign tumor of adrenal cortex
Usually incidental but can occasionally produce excess aldosterone -> secondary HTN (Conn syndrome)
Majority of AAs have 2 properties that allow for imaging diagnosis: Microscopic fat and/or rapid washout characteristics on CECT.
Nodule <=10 HU on NECT can be reliably diagnosed as AA
75% of AAs measure <10HU on NECT = lipid-rich
25% of AAs measure >10 HU on NECT (lipid-poor) and require CECT to assess washout characteristics.
AA washout characteristics: absolute WO >60% or a relative WO >40%
If nodule does not meet CT density or WO criteria for AA, it is considered indeterminate.
In practice, an indeterminate adrenal nodule in a patient w/o known malignancy most likely represents a lipid-poor adenoma and advanced imaging is usually NOT required.
If dx is requried for further management (lung CA w/o known mets), further WU is based on lesion size, hx of malignancy, and availability of prior imaging. In some cases, FDG PET/CT and BX are helpful.
BX is indicated for an adrenal mass that remains indeterminate after comprehensive imaging workup, particulalry in the context of underlying malignancy.
Collision tumor: coexistence of 2 tumors w/n an adrenal mass, such as mets w/n an adrenal adenoma or myelolipoma.
If a lesion appears heterogeneous or shows an interval increase in size, then a collision tumor should be considered in patients w/ a known primary malignancy, even if a portion of the lesion is <10 HU.
MRI - chemical shift imaging
Lipid rich adenomas contain intracytoplasmic lipid which MRI can detect by taking advantage of the fact that protons resonate at different frequencies in fat and in water.
benign neoplasm consisting of myeloid cells (erythrocyte precursors) and fat cells.
In rare cases, they can be extraadrenal and are pathologically indistinguishable from extramedullary hematopoiesis which occurs in patients w heme dz
Adrenal mass w/ macroscopic/gross fat is diagnostic of myelolipoma
Usually incidental and can be large (>4 cm) at time of diagnosis.
Few reports of adrenocortical carcinoma and metastatic carcinoma w/ macroscopic fat.
A retroperitoneal liposarcoma may mimic a myelolipoma, although liposarcoma typically presents as a large mass that may displace, rather than arise from, the AG.
Adrenal myelolipoma and renal AML are NOT the same. These entities are unrelated but both diagnosed by the presence of macroscopic fat.
Relatively uncomm on but have typical characteristics of benign cysts that occur elsewhere in the body: internal fluid content w/ thin, smooth, nonenhancing wall.
Endothelial adrenal cyst: MC (45%) type and may be lymphatic or angiomatous in origin.
Pseudocyst: 2/2 adrenal hemorrhage represents 39% and lack epithelial lining. peripheral calcs may be present.
Epithelial cysts: rare, 9%
Occasionally an AC may have a complex appearance and can be difficult to differentiate from a cystic/necrotic neoplasm. -> percutaneous aspiration or surgical resection may be considered.
Small, asx simple cysts can be ignored.
A cyst may rarely grow so large as to cause sx, such as dull pain or compression of the stomach/duodneum.
VERY rarely, hydatic dz may affect the AGs and produce a complex cystic lesion w/ an internal membrane.
Intra-adrenal paraganglioma; neuroendocrine tumor that typically originates from the adrenal medulla.
Composed of chromaffin cells that secrete catecholamines and cause uncontrolled secondary HTN and episodic headaches/diaphoresis.
Hereditary type: small bilateral adrenal lesions in young patient.
Sporadic type: large > 3 cm, unilateral mass in older pt
Syndromes:
MEN2A/B: b/l intraadrenal pheos
NF1
vHL
Carney's triad (gastric leiomyosarcoma, pulmonary chondroma, paraganglioma)
Hereditary paraganglioma-pheochromocytoma syndrome: SDHD gene mutation.
90% RULE: 90% arise in adrenal, 90% unilateral, ~90% are benign
Called paraganglioma when tumor arises in other chromaffin cells of sympathetic ganglia. Typically subdiaphragmatic but can be anywhere along sympathetic chain from neck to bladder.
Organ of Zuckerkandl (along Ao bifurcation to level of bladder) and urinary bladder are relatively common sites.
If urinary bladder is involved, it can produce post-micturation syncope.
IMAGING FEATURES
CANNOT be distinguished from other tumors by imaging alone. Need clinical hx and lab values (urinary and plasma fractionated metanephrines)
Highly vascular and prone to hemorrhage
US: hypoechoic suprarenal lesion +/- cystic change
NECT: >10 HU
CECT:
Delayed washout kinetics typically similar to adrenal CA and mets, but rapid washout like adenoma is possible.
Heterogeneous enhancement 2/2 necrosis, cystic degeneration, hemorrhage.
MR: Variable T1/T2 signal 2/2 hemorrhage, cystic degeneration, necrosis; T2 light bulb hyperintensity
Ga-68 DOTATATE: ectopic, recurrent and metastatic tumors. (see below)
Very rare w prevalence approx 1/1,000,000. Highly aggressive w/ poor prognosis
~66% are functional producing a disordered array of hormones that may manifest as Cushing syndrome, hyperaldosteronism, and virilization.
Imaging:
Large >4 cm and unilateral; irregular tumor margins
Central necrosis/hemorrhage w/ heterogeneous enhancement.
Calcification is common. Fat is rare.
Early local vascular invasion of renal vein or IVC
20% have distant mets at presentation lungs, liver nodes, bone.
4th MC site of hematogenous mets after lungs, liver and bone.
Adrenal mets are present >25% of patients w known primary malignancy.
Melanoma (50%), lung/breast (30-40%), renal/GIT (10-20%)
Rich adrenal blood supply for endocrine function. As a result, adrenal glands are common site for hematologic mets (lung, breast, melanoma)
Unilateral or bilateral; central necrosis +/- hemorrhage
Usually <5 cm, larger if melanoma.
Must differentiate b/n isolated benign adrenal lesion (typically adenoma) and mets during initial staging:
Most mets show prolonged washout pattern unlike adenoma.
Rapid washout if hypervascular mets.
Can be spontaneous but in adults is usually due to anticoagulation or an underlying malignancy.
Hemorrhage can appear mass-like and is often heterogeneous on CT but does not enhancement of postcontrast images.
When prior imaging is available, it should be suspected in the event of rapid onset of an adrenal mass.
In this context F/U imaging can be helpful to confirm resolution and/or interval decrease in size.
ADRENAL CALCIFICATION
Not infrequent but rarely cause adrenal hypofunction.
Can be 2/2 hemorrhage, granulomatosis w polyangiitis, TB, and histoplasmosis.
ADRENAL HYPERPLASIA
Enlargment of adrenal glands
Adrenal body > 10 mm, limbs >5 mm
Typically bilateral and smooth w/ maintained shape
Majority are nonfunctional. minority demonstrate subclinical or clinical adrenal dysfunction.